Clinical trial · Interventional
A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy
A Prospective, Randomized, Single-blind, Parallel-controlled Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Colonoscopy is a key technique in the detection and diagnosis of lower gastrointestinal diseases. High quality endoscopy results in better disease outcomes. However, the operant level of different endoscopists is significantly different.This study aims to construct a real-time quality monitoring system based on computer vision, named Endo.Angel, which is used to monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenoma | Adenoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Colonoscopy with assistance of Endo.Angel | Diagnostic Test | — | UNRESOLVED |
| Colonoscopy without assistance of Endo.Angel | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Exposed group
- description
- Patients will receive colonoscopy with assistance of Endo.Angel
- interventionNames
- Diagnostic Test: Colonoscopy with assistance of Endo.Angel
- type
- SHAM_COMPARATOR
- label
- Non-exposed group
- description
- Patients will receive colonoscopy without assistance of Endo.Angel
- interventionNames
- Diagnostic Test: Colonoscopy without assistance of Endo.Angel
Primary outcomes (1)
- measure
- Adenoma detection rate
- timeFrame
- 3 months.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Men or women over the age of 18 years old; 2. Ability to read, understand and sign informed consent; 3. The investigator believes that the subject understands the flow of the clinical study and is willing and able to complete all the research procedures and follow-up visits in conjunction with the research procedure. Exclusion Criteria: 1. Colonoscopy patients with absolute contraindications; 2. patients with biopsy contraindications; 3. inflammatory bowel disease, colorectal cancer, history of colorectal surgery; 4. women during pregnancy or lactation; 5. Patients with multiple polyposis syndrome; 6. Patients with known or suspected intestinal obstruction or perforation 7. Previously failed colonoscopy; 8. The investigator believes that the subject is not suitable for high-risk disease or other special conditions in clinical trials.
References
Publications (0)
Data not yet available